1-2 of 2
Teresa Parli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in High-Risk and/or Stage 23 Relapsed and/or Refractory Multiple Myeloma: A Retrospective Subset Analysis of the Phase 2 Study,

Sundar Jagannath, MD, Sagar Lonial, MD, Andrzej J Jakubowiak, MD, Thierry Facon, MD, Ravi Vij, MD, Marc S Raab, MD, PhD, Darrell J. White, MD, Min-Hui Wang, PhD, Teresa Parli, MD, Blake J Bartlett, PhD, Anil K Singhal, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2011) 118 (21): 3968.
https://doi.org/10.1182/blood.V118.21.3968.3968
Published: 2011
Journal Articles

A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Sagar Lonial, MD, Andrzej J Jakubowiak, MD, PhD, Sundar Jagannath, MD, Marc S Raab, MD, PhD, Thierry Facon, MD, Ravi Vij, MD, Philippe Moreau, MD, Donna E. Reece, MD, FRCPC, Darrell J. White, MD, Lotfi Benboubker, MD, PhD, Jeffrey A. Zonder, MD, Jean-Francois Rossi, MD, PhD, Claire Tsao, Teresa Parli, Glenn Kroog, MD, Anil K Singhal, Paul G. Richardson, MD
Journal: Blood
Blood (2011) 118 (21): 303.
https://doi.org/10.1182/blood.V118.21.303.303
Published: 2011